Master data| INID | Criterion | Field | Content |
|---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
| 21 | DE file number | DAKZ | 698 04 034.1 |
| 96 | EP file number | EAKZ | 98 30 2789.7 |
| 97 | EP publication number | EPN | 872238 |
| 54 | Designation/title | TI | Verwendung von Olanzapin zur Herstellung eines Arzneimittels zur Neuroprotektion |
| 51 | IPC main class | ICM
(ICMV) | A61K 31/55 (2006.01) |
| 22 | DE application date | DAT | Apr 9, 1998 |
| 96 | EP application date | EAT | Apr 9, 1998 |
| 43 | Date of first publication | OT | Oct 21, 1998 |
| Date of publication of grant | PET | Mar 6, 2002 |
| 71/73 | Applicant/owner | INH | Eli Lilly and Co., Indianapolis, Ind., US |
| 72 | Inventor | IN | Bymaster, Franklin Porter, Brownsburg, Indiana 46112, US; Tollefson, Gary Dennis, Indianapolis, Indiana 46236, US |
| 74 | Representative | VTR | Kroher - Strobel Rechts- und Patentanwälte PartmbB, 80336 München, DE |
| 10 | Published DE documents | DEPN | Original document:
DE000069804034T2
Searchable text:
DE000069804034T2 |
| Address for service | | Kroher - Strobel Rechts- und Patentanwälte PartmbB, 80336 München, DE |
33
31
32
| Foreign priority | PRC
PRNA
PRDA
| US
43094 P
Apr 15, 1997
|
| Patent division in charge | | 44 |
| 97 | EP language of publication | ELANG | EN - Englisch |
| 84 | Designated EP contracting states | EDS | AT, BE, CH, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, NL, PT, SE |
| 43 | Date of first publication | EVT | Oct 21, 1998 |
| Date of the first transfer into DPMAregister | EREGT | Sep 28, 2012 |
| Date of the (most recent) update in DPMAregister | REGT | Mar 25, 2015
(Show all update days)(Hide all update days)- Mar 25, 2015; Jan 21, 2013
- Historical data not available for this/these date(s)
- Sep 28, 2012
- Date of the first transfer into DPMAregister
|
